Indian Journal of Rheumatology

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 15  |  Issue : 2  |  Page : 116--121

Clinical Outcomes in Patients with Cardiac Lupus: A Retrospective Study


K Maria Koshy1, Tarun George1, Sohini Das1, JV Punitha1, Sudha Jasmine Rajan1, Bijesh Yadav2, Thambu David Sudarsanam1, Vijay Prakash Turaka1 
1 Department of Medicine, Christian Medical College, Vellore, Tamil Nadu, India
2 Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India

Correspondence Address:
Dr. Vijay Prakash Turaka
Department of Medicine, Unit 2, Christian Medical College, Vellore - 632 004, Tamil Nadu
India

Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect every organ system. The study aimed to analyze the clinical manifestations, laboratory findings, antibody associations, and clinical outcomes of patients with cardiac lupus. Materials and Methods: Biomedical records of patients admitted during 2014–2017 who had a diagnosis of SLE were reviewed. Using predetermined inclusion criteria patients with cardiac lupus were identified. Disease manifestations, antibody associations, and clinical outcomes were studied. The Cox proportional hazards model was used to study factors associated with mortality. Results: Over a 3-year period, a total of 372 were admitted with a diagnosis of SLE, out of which 59 patients with cardiac lupus were identified. The patients were predominantly female (86.4%), fever and breathlessness were most common symptoms and the median SLE disease activity index score was 18. Myocardial disease (66.1%), pericardial disease (30.5%), and pulmonary artery hypertension (23.7%) were the most common cardiac manifestations. The mean ejection fraction was 46% ±11.4% with left ventricular systolic dysfunction present in 65.5% (n = 36). The inpatient mortality rate was 22% (n = 13). An elevated serum creatinine, elevated creatine Kinase–muscle/brain, neutrophilic leukocytosis, left ventricular systolic dysfunction, noninitiation of hydroxychloroquine, and the presence of neuropsychiatric lupus predicted mortality. On follow-up, 12 of the 13 echocardiograms demonstrated normal findings. Conclusion: Cardiac disease affects a significant proportion of patients with lupus. A high mortality rate as evident from this study, highlights the importance of recognizing the cardiac complications of SLE. Clinicians should diligently search for the same, as early interventions could reduce mortality and morbidity.


How to cite this article:
Koshy K M, George T, Das S, Punitha J V, Rajan SJ, Yadav B, Sudarsanam TD, Turaka VP. Clinical Outcomes in Patients with Cardiac Lupus: A Retrospective Study.Indian J Rheumatol 2020;15:116-121


How to cite this URL:
Koshy K M, George T, Das S, Punitha J V, Rajan SJ, Yadav B, Sudarsanam TD, Turaka VP. Clinical Outcomes in Patients with Cardiac Lupus: A Retrospective Study. Indian J Rheumatol [serial online] 2020 [cited 2020 Nov 28 ];15:116-121
Available from: https://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=2;spage=116;epage=121;aulast=Koshy;type=0